Tablet production at one of AstraZeneca ’ s manufacturing sites
“ Generative AI has the potential to transform the pharmaceutical manufacturing industry ”
RAAJ JOSHI DIRECTOR OF FINANCIAL CONTROLS AND COMPLIANCE TRANSFORMATION , ASTRAZENECA
So far this year , AstraZeneca has acquired two companies . Icosavax , Inc ., is a clinical-stage biopharmaceutical company based in Seattle , which develops high-potential vaccines using a protein virus-like particle platform . The second is Gracell Biotechnologies Inc ., another clinical-stage biopharmaceutical company , which develops cell therapies for the treatment
88 April 2024